摘要
外科肺活检由于能提供更多的信息,对弥漫性实质性肺疾病(DPLD)诊治具有重要价值,被多数指南推荐为确诊的主要手段。然而,随着新的无创或微创等手段在DPLD诊治中的运用,SLB在DPLD诊断中的地位和应用价值需要再评估。
Surgical lung biopsy(SLB)has been clearly recommended for the diagnosis of diffuse parenchymal lung disease(DPLD)in major guidelines because it provides the largest and most informative tissue samples.However,with the use of new non-invasive or minimally invasive tools in the diagnosis and treatment of DPLD,the dominance of SLB as the gold standard in the diagnosis of DPLD has been questioned,the diagnostic value of SLB for diffuse parenchymal lung should be re-evaluated.
作者
施举红
Shi Juhong(Department of Pulmonary and Critical Care Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China)
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
2022年第3期243-246,共4页
Chinese Journal of Tuberculosis and Respiratory Diseases